Real-life Data of Constitutional Von Willebrand Disease in Western France

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

922 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-07

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this observational study HOPSCOTcH-WILL II is to provide an accurate and detailed account of current Von Willebrand Disease (VWD) therapeutic management by collecting real-life data on hemorrhagic treated events in the 5 Western French Hemophilia Treatment Center.

The HOPSCOTCH-WILL II study aims to describe therapeutic management of patients with VWD, following the provision of a recombinant drug in France; It will also permit to carry out a budget impact analysis to quantify the economic significance of this new era.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Registry of Patients With Von WilLEbrand Disease Treated With Voncento®

NCT04657887

Von Willebrand Disease

COMPLETED

Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease

NCT06651255

Von Willebrand Disease (VWD)

NOT_YET_RECRUITING NA

Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding

NCT02792205

Von Willebrand Disease

COMPLETED

Effectiveness and Tolerability of Eqwilate in Real-life Conditions

NCT04106908

VWD - Von Willebrand's Disease

ACTIVE_NOT_RECRUITING

National Study of Moderate and Severe Von Willebrand Disease in the Netherlands

NCT00510042

Von Willebrand Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Von Willebrand Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

no intervention

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Constitutional Von Willebrand Disease patient, of any severity, with or without Von Willebrand Factors inhibitors
* Patient included in the research database BERHLINGO
* Patient treated or not by desmopressin or Von Willebrand Factor/FVIII/by-passing agents available on the French market (at baseline)
* Patient who agrees to participate in the HOPSCOTcH-Will II and followed in one of the 5 investigator centers